As Steris prepares to report its fiscal fourth-quarter results, investors are watching to see if the company can maintain its recent streak of topping revenue estimates against a backdrop of mixed signals from the broader healthcare equipment sector.
Blue Bird Corporation (BLBD) is poised to release its latest quarterly results after Wednesday's market close. Investors will be watching to see if the manufacturer can maintain its pattern of outperforming Wall Street's forecasts amidst a mixed landscape for heavy equipment peers.
The affordable cosmetics giant e.l.f. Beauty is poised to release its fourth-quarter financial results this week, following a period of robust stock performance and mixed signals from the broader consumer staples sector.
CME Group is set to report fourth-quarter earnings Wednesday morning, with analysts forecasting a 7.8% revenue increase. The derivatives exchange operator's performance may signal broader capital markets health as peers post mixed results.
The global electronics manufacturer is poised to release its quarterly results Wednesday, with investors watching for signs of stabilization after a period of revenue contraction.
Payment technology firm WEX Inc. is set to release its quarterly financial results after Wednesday's market close, with Wall Street anticipating a return to revenue growth following last year's dip.
Silgan Holdings is set to report fourth-quarter earnings Wednesday morning, with Wall Street eyeing slowing revenue growth and the company's ability to outperform in a mixed industrial packaging landscape.
Amgen has terminated its collaboration with Kyowa Kirin on the atopic dermatitis drug rocatinlimab, handing full development rights back to the Japanese partner. The strategic shift comes as Amgen's stock trades above most fair value estimates, raising questions about its current valuation amid pipeline recalibration.
Stanley Black & Decker announces key leadership changes, appointing a new General Counsel and adding fresh expertise to its board. The moves signal a deeper focus on governance and operational oversight as the company navigates its financial turnaround.
A Wells Fargo upgrade highlights ConocoPhillips' robust cash flow trajectory and strategic projects, positioning the energy giant for significant dividend growth over the next five years.
Palantir Technologies' stock surged after hours as the data analytics firm reported record quarterly results, fueled by its AI platform. CEO Alex Karp hailed an 'iconic' performance while warning that the company's dominance creates societal and political tensions.
Vera Therapeutics appoints industry veteran Matt Skelton as Chief Commercial Officer, signaling a strategic pivot toward commercialization as its lead drug candidate for IgA nephropathy, atacicept, undergoes FDA Priority Review.
Kemper Corporation is set to report its fourth-quarter earnings Wednesday afternoon, with investors watching closely for signs of stability after a period of mixed performance and sector-wide pressure.
As Equitable Holdings prepares to report fourth-quarter results, investors are watching for signs of stability amid a turbulent period for insurance stocks. With revenue growth expected to stall, the focus shifts to profitability and guidance.
As Regal Rexnord prepares to release its fourth-quarter results, investors are watching to see if the industrial automation leader can sustain its recent stock momentum and deliver on growth forecasts in a mixed earnings season for machinery peers.
Offshore drilling contractor Noble Corporation bolsters its forward workload with a series of new multi-year contracts totaling approximately $1.3 billion, headlined by a major harsh-environment rig award in Norway, signaling a strategic geographic expansion and renewed confidence in the offshore cycle.
As Kulicke & Soffa prepares to release its fourth-quarter results, investors are watching to see if the semiconductor equipment specialist can meet elevated expectations amid a sector-wide rebound.
Elon Musk announces the merger of SpaceX and xAI, outlining an ambitious plan to construct solar-powered data centers in space, which he claims will become the most cost-effective source of AI computing power within years.
The pharmaceutical giant is set to release quarterly results before the bell Wednesday, with Wall Street anticipating another period of blockbuster revenue growth driven by its GLP-1 drugs.
Aerospace and defense component maker Woodward, Inc. (WWD) is commanding investor attention following a robust first-quarter earnings beat, a significant dividend hike, and an upgraded full-year outlook. The strong results have propelled the stock to new highs, reigniting the debate over its valuation in a rapidly evolving industry.
